Achieving Targeted Treatment Outcomes in IBD : Episode 6
Unmet Needs and Starting Advanced Treatment in Inflammatory Bowel Disease
Silvio Danese, MD, PhD; Bruce Sands, MD, and Jean-Frederic Colombel, MD, highlight the common practice in many community settings of treating inflammatory bowel disease (IBD) with corticosteroids, with or without 5-aminosalicylic acid, and cycling patients through this regimen for prolonged periods, while emphasizing the significant impact and toxicities associated with this treatment approach.
EP: 1.Treat-to-target in Inflammatory Bowel Disease
EP: 2.Recommended Targets When Treating Ulcerative Colitis/Crohn’s Disease in Clinic
EP: 3.Transmural Healing and Monitoring in Ulcerative Colitis and Crohn’s Disease
EP: 4.Implementing Treat to Target in the Long-term in Inflammatory Bowel Disease
EP: 5.Suboptimal Treatment of Inflammatory Bowel Disease in Clinical Practice
Now Viewing
EP: 6.Unmet Needs and Starting Advanced Treatment in Inflammatory Bowel Disease
EP: 7.Considerations for Choosing Advanced Treatments and Setting Patient Expectations
EP: 8.Combination Therapy in Inflammatory Bowel Disease
EP: 9.Measuring Patient Satisfaction with Inflammatory Bowel Disease Treatments and Communication Regarding Treatment Changes
- When should clinicians start thinking about starting advanced targeted therapies for patients with UC or CD?
Recent Videos
Related Content
